Login / Signup

Panuveitis induced by brentuximab vedotin: a possible novel adverse event of an antibody-drug conjugate.

Philippos Apolinario CostaAndrea Patricia Espejo-FreireKenneth Chen FanThomas Arno AlbiniGeorgios Pongas
Published in: Leukemia & lymphoma (2021)
Keyphrases
  • hodgkin lymphoma
  • cancer therapy
  • adverse drug
  • emergency department